Live Analyst Rating Changes 3274 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ivan Bokhmat
BARC
Ivan Bokhmat
Barclays
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+28.8%
Average Return
1 of 1 calls profitable · +6.9% vs benchmark
📈 Across the calls we could measure, roughly 100% of Ivan Bokhmat's ratings turned a profit when each position was held for 1 year — averaging +28.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

37 Buy 19 Hold 26 Sell
Ivan's Stock Coverage 19 ratings · 2026-06-27
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GB:HSX
Hiscox
 May 26, 2026 BUY Strong Buy
+278.1% avg upside
15 analysts
$1820.00
1.94% Downside
 ·
GB:CRE
Conduit Holdings Ltd
 May 26, 2026 SELL Buy
+5.0% avg upside
6 analysts
$410.00
13.25% Downside
 ·
CH:SREN
Swiss Re AG
 May 26, 2026 SELL Hold
-4.8% avg upside
15 analysts
$113.00
11.58% Downside
 ·
GB:LRE
Lancashire Holdings
 May 26, 2026 HOLD Hold
+533.3% avg upside
12 analysts
$610.00
5.09% Downside
 ·
DE:MUV2
Munich Reinsurance
 May 26, 2026 BUY Buy
+1.4% avg upside
17 analysts
$575.00
20.37% Upside
 ·
DE:HNR1
Hannover Rueck
 May 26, 2026 SELL Buy
+11.8% avg upside
16 analysts
$246.00
3.17% Upside
 ·
FR:SCR
SCOR
 May 25, 2026 HOLD Buy
-1.2% avg upside
12 analysts
$31.50
1.44% Downside
 ·
GB:SBRE
Sabre Insurance Group plc
 May 22, 2026 BUY Buy
+4.0% avg upside
6 analysts
$181.00
5.79% Upside
 ·
GB:AV
Aviva plc
 Feb 06, 2026 HOLD Buy
-1.1% avg upside
17 analysts
$690.00
6.60% Upside
 ·
GB:ADM
Admiral
 Jan 29, 2026 BUY Hold
-12.2% avg upside
14 analysts
$3264.00
7.44% Downside
 ·
GB:BEZ
Beazley
 Nov 25, 2025 BUY Strong Buy
+158.1% avg upside
14 analysts
$1020.00
20.64% Downside
 ·
GB:PRU
Prudential
 Oct 30, 2025 BUY Strong Buy
+818.4% avg upside
23 analysts
$1260.00
25.28% Upside
 ·
ES:MAP
Mapfre, SA
 Apr 11, 2023 SELL Strong Sell
-27.6% avg upside
3 analysts
$1.75
59.48% Downside
 ·
DE:ALV
Allianz
 Jun 30, 2022 HOLD Buy
-11.3% avg upside
23 analysts
 — ·
CH:ZURN
Zurich Insurance Group
 Jun 30, 2022 BUY Hold
-1.8% avg upside
15 analysts
 — ·
FR:CS
AXA SA
 Jun 30, 2022 BUY Strong Buy
+2.6% avg upside
18 analysts
 — ·
IT:G
Assicurazioni Generali S.p.A.
 Jun 30, 2022 SELL Hold
-15.4% avg upside
16 analysts
 — ·
NL:NN
NN Group N.V.
 Feb 18, 2019 SELL Buy
-11.5% avg upside
12 analysts
$110.50
44.78% Upside
 ·
SSREY
Swiss Re
 Dec 13, 2018 BUY Strong Buy
+232.0% avg upside
4 analysts
$125.59
218.93% Upside
 +28.8%
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ivan Bokhmat — Frequently Asked Questions
How accurate are Ivan Bokhmat's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Ivan's ratings were profitable over a one-year hold, with an average return of +28.8% per rating, or +6.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Ivan ranked on 13Foresight?
Ivan Bokhmat is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ivan cover?
Ivan most recently has ratings on GB:HSX, GB:CRE, CH:SREN, GB:LRE, DE:MUV2, DE:HNR1, FR:SCR, GB:SBRE, GB:AV, GB:ADM, GB:BEZ, GB:PRU and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.